Congrats Leo! PR worded a little differently but t
Post# of 72440
The proposed research of Birlicidan will be conducted by a US Regional Biocontainment Lab With free Federal Grants!!! They will evaluate Brilacidin as a potential pan-coronavirus therapeutic, for treating SARS-CoV-2, SARS-CoV-1 and MERS-CoV, including extending the current in vitro testing of Brilacidin to in vivo testing.
Longer-term objectives include potentially performing additional research to develop Brilacidin as a broad-spectrum antiviral, with possible application beyond coronaviruses, e.g., treating other viruses, such as encephalitic alphaviruses and filoviruses.
Net/Net it's a Potential RARE HOME RUN against this Pandemic and Broad Spectrum antivirals and a Boon for Researchers, Innovation Pharmaceuticals and investors$$$!!! Expect game changing PR's soon!
Read More: https://investorshangout.com/post/view?id=579...z6P3fi11dz